Grant - PineTree Therapeutics
Investment Firm
Overview
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Announced Date
Sep 27, 2022
Funding Type
Grant
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Massachusetts Life Sciences Center |
Round Details and Background
PineTree Therapeutics raised an undisclosed amount on 2022-09-27 in Grant
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 07, 2022 |  Series A - PineTree Therapeutics | 6 | - | 23.5M |
| Sep 27, 2022 | Grant - PineTree Therapeutics | 1 | - | undefined |
| Jul 30, 2024 | Series A - PineTree Therapeutics | 7 | - | 17.0M |
Recent Activity
There is no recent news or activity for this profile.